Has Neil Patel, DPM received payments from drug or device companies?

Yes. Drug and device makers reported $20,786 in general payments to Neil Patel, DPM across 253 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Neil Patel, DPM did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Neil Patel, DPM come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Neil Patel, DPM

Foot & Ankle Surgery · la Verne, CANPI 1093262099

Payments from drug & device makers

$20,786in general payments, 2019–2025

Across 253 payments — averaging $82.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Zimmer Biomet$3K
Stryker$3K
Arthrex$3K
Biotissue Holdings Inc.$2K
Integra Lifesciences Corporation$2K
Mid-atlantic Surgical Systems, LLC$1K
plus $5K from 27 others

What the payments were for

Consulting fees$7504%
Travel & lodging$3,42516%
Food & beverage$12,58561%
Education$4,02619%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Zimmer Biomet	42	$3,298
Stryker	49	$3,187
Arthrex	12	$3,013
Biotissue Holdings Inc.	23	$2,332
Integra Lifesciences Corporation	25	$2,296
Mid-atlantic Surgical Systems, LLC	2	$1,174
Smith+Nephew	41	$1,160
Treace Medical Concepts, Inc.	11	$1,008
Acera Surgical, Inc.	5	$608
Musculoskeletal Transplant Foundation Inc.	4	$480
Linvatec Corporation	2	$263
In2bones USA, LLC	2	$233
Johnson & Johnson	2	$210
Amgen(2 entities)	4	$206
Ossio Inc	2	$204
Medline Industries LP	2	$145
Aroa Biosurgery Incorporated	2	$144
Medartis Inc.	2	$129
Amniox Medical, Inc.	4	$114
Lifenet Health	1	$96
Organogenesis Inc.	2	$95
Solventum Corporation	2	$71
Next Science LLC	1	$64
Paratek Pharmaceuticals, Inc.	2	$52
Polynovo North America LLC	1	$36
Corcept Therapeutics	1	$33
KCI USA, Inc.	1	$31
Vertex	1	$28
Orthofix Medical, Inc.	1	$18
Kowa Pharmaceuticals America, Inc.	1	$16
Tactile Systems Technology Inc	1	$16
Abbott	1	$15
Bioventus LLC	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

INTEGRA$3,059
Stratum Foot Plating System$1,707
INTEGRA DERMAL REGENERATION TEMPLATE$1,020
PRIMATRIX$1,020
Lapiplasty System$860
NEOX$778
CLARIX$778
HOFFMANN$639
Restrata Wound Matrix$510
SALTO TALARIS TOTAL ANKLE PROSTHESIS$328
CADENCE ANKLE REPLACEMENT SYSTEM$328
HALLU-LOCK$328
PANTA NAIL$328
TOTAL FOOT SYSTEM$328
AUGMENT INJECTABLE$296
Stravix$240
BME NITINOL CONTINUOUS COMPRESSION IMPLANTS$210
SALVATION$175
ALLOMATRIX$171
ORTHOLOC 2 LAPIFUSE$170

How this compares

$20,786 in reported general payments places this provider in the 90th percentile of 1,126 foot & ankle surgery providers in California.

See all foot & ankle surgery providers in California →

Medicare billing

Part B allowed, 2024

$3,511,335

Medicare patients

708

Services billed

3,211

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Doxycycline Monohydrate	21	$425

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in la Verne

John ZimmermanBakersfield$4.6M
Eric GizaSacramento$3.7M
Thomas HarrisPasadena$3M
Felix SigalLos Angeles$2.2M
Thomas ChangSanta Rosa$2.1M
Michael CoughlinSan Francisco$1.6M
Vladimir ZeetserEncino$677K
Jason NowakRedding$526K
Candice BradyCamarillo$462K
Andrew HsuOrange$456K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →